Abstract:Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by complex pathophysiological features. Amyloid plaques resulting from extracellular amyloid deposition and neurofibrillary tangles formed by intracellular hyperphosphorylated tau accumulation serve as primary neuropathological criteria for AD diagnosis. The activation of microglia has been closely associated with these pathological manifestations. Non-coding RNA (ncRNA), a versatile molecule involved in various cellular functions such as genetic information storage and transport, as well as catalysis of biochemical reactions, plays a crucial role in microglial activation. This review aims to investigate the regulatory role of ncRNAs in protein expression by directly targeting genes, proteins, and interactions. Furthermore, it explores the ability of ncRNAs to modulate inflammatory pathways, influence the expression of inflammatory factors, and regulate microglia activation, all of which contribute to neuroinflammation and AD. However, there are still significant controversies surrounding microglial activation and polarization. The categorization into M1 and M2 phenotypes may oversimplify the intricate and multifaceted regulatory processes in microglial response to neuroinflammation. Limited research has been conducted on the role of ncRNAs in regulating microglial activation and inducing distinct polarization states in the context of neuroinflammation. Moreover, the regulatory mechanisms through which ncRNAs govern microglial function continue to be refined. The current understanding of ncRNA regulatory pathways involved in microglial activation remains incomplete and may be influenced by spatial, temporal, and tissue-specific factors. Therefore, further in-depth investigations are warranted. In conclusion, there are ongoing debates and uncertainties regarding the activation and polarization of microglial cells, particularly concerning the categorization into M1 and M2 phenotypes. The study of ncRNA regulation in microglial activation and polarization, as well as its mechanisms, is still in its early stages and requires further investigation. However, this review offers new insights and opportunities for therapeutic approaches in AD. The development of ncRNA-based drugs may hold promise as a new direction in AD treatment.

NcRNAs: A Synergistically Antiapoptosis Therapeutic Tool in Alzheimer's Disease

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease

Non-coding RNAs involved in the molecular pathology of Alzheimer's disease: a systematic review

The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer's Disease

Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance

Editorial: Noncoding RNAs in neurodegenerative disorders: from current insights and future directions to translational modeling and therapeutic approaches

The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers

Research Progress on Lncrnas in Alzheimer's Disease.

The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease

The Association between Long Non-Coding RNAs and Alzheimer's Disease

Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease

Insights from Non-Coding RNAs

Insights into Lncrnas in Alzheimer's Disease Mechanisms.

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer's Disease

The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease and May Serve as Potential Biomarkers

Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis

Regulation of LncRNAs and microRNAs in neuronal development and disease

CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer’s Disease Involved the Cgmp-Pkg Signal Pathway